
PMC:7103735 / 48535-49113
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T441 | 35-43 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T442 | 35-39 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T443 | 75-83 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T444 | 75-79 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T445 | 117-125 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T446 | 117-121 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T447 | 306-315 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T448 | 386-394 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T449 | 386-390 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T450 | 555-563 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T451 | 555-559 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T546 | 173-179 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T547 | 316-323 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T548 | 571-577 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T138 | 4-13 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | virulence |
T139 | 4-13 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | virulence |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T404 | 0-113 | Sentence | denotes | The virulence and pathogenicity of SARS-CoV-2 seem to lie between those of SARS-CoV and community-acquired HCoVs. |
T405 | 114-341 | Sentence | denotes | If SARS-CoV-2 becomes more attenuated as it adapts well in humans and increases its person-to-person transmissibility as anticipated, similar strategies for prevention and control of CoVs and influenza viruses might be adopted. |
T406 | 342-426 | Sentence | denotes | To reduce morbidity and mortality caused by SARS-CoV-2, vaccines could be developed. |
T407 | 427-578 | Sentence | denotes | If quarantine cannot contain the spreading and if it is necessary, vaccination will provide the second opportunity to eradicate SARS-CoV-2 from humans. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1396 | 35-45 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1397 | 75-83 | Species | denotes | SARS-CoV | Tax:694009 |
1398 | 117-127 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1399 | 173-179 | Species | denotes | humans | Tax:9606 |
1400 | 297-301 | Species | denotes | CoVs | Tax:11118 |
1401 | 306-323 | Species | denotes | influenza viruses | Tax:11308 |
1402 | 386-396 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1403 | 555-565 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1404 | 571-577 | Species | denotes | humans | Tax:9606 |
1405 | 366-375 | Disease | denotes | mortality | MESH:D003643 |